AnalystsJeffrey Hung
Jeffrey Hung's Stock Forecasts

Analyst Ranking
Top 17%
#829 out of 4868 analysts
Average Return
+4.97%
Win Rate
48%45 out of 94
Risk vs Reward
Poor
Good

Jeffrey Hung's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Myokardia IncMYOK
+314.95%$53.26$221.00
2020-04-14 -
2020-10-06
Strong Buy
Cytokinetics IncCYTK
+182.40%$33.19$93.73
2023-08-03 -
2024-01-05
Strong Buy
Cytokinetics IncCYTK
+151.83%$37.22$93.73
2023-06-21 -
2024-01-05
Strong Buy
Disc Medicine IncIRON
+108.90%$28.10$58.70
2023-04-19 -
2023-12-19
Strong Buy
Evofem Biosciences IncEVFM
+95.55%$10.75$0.48
2021-10-13 -
2022-08-10
Strong Sell

Jeffrey Hung's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Engene Holdings IncENGN
3Strong Buy$34.00+721.26%Maintains
2 months ago
Rhythm Pharmaceuticals IncRYTM
10Strong Buy$72.00+10.45%Assumes
2 months ago
Ptc Therapeutics IncPTCT
11Strong Buy$70.00+40.45%Assumes
2 months ago
Neurocrine Biosciences IncNBIX
11Strong Buy$150.00+39.29%Assumes
2 months ago
Jazz Pharmaceuticals PLCJAZZ
5Strong Buy$183.00+56.46%Assumes
2 months ago
Erasca IncERAS
3Strong Buy$4.00+173.97%Assumes
2 months ago
Disc Medicine IncIRON
6Strong Buy$85.00+72.00%Assumes
2 months ago
Cullinan Therapeutics IncCGEM
5Strong Buy$35.00+322.71%Assumes
2 months ago
Contineum Therapeutics IncCTNM
2Strong Buy$25.00+508.27%Assumes
2 months ago
Cg Oncology IncCGON
2Strong Buy$55.00+104.16%Assumes
2 months ago
Centessa Pharmaceuticals PLCCNTA
2Strong Buy$27.00+96.94%Assumes
2 months ago
Bioage Labs IncBIOA
2Strong Sell$5.00+19.05%Assumes
2 months ago
Acadia Pharmaceuticals IncACAD
19Hold$20.00+36.99%Assumes
2 months ago
Cytokinetics IncCYTK
7Strong Buy$67.00+56.40%Upgrades
3 months ago
Amicus Therapeutics IncFOLD
4Hold$12.00+56.25%Downgrades
5 months ago
Intra Cellular Therapies IncITCI
5Strong Buy$95.00-27.96%Maintains
7 months ago
Cervomed IncCRVO
1Strong Buy$35.00+286.31%Initiates Coverage On
9 months ago
Crinetics Pharmaceuticals IncCRNX
2Strong Buy$70.00+109.64%Maintains
a year ago
Karuna Therapeutics IncKRTX
3Hold$330.00N/ADowngrades
a year ago
Prelude Therapeutics IncPRLD
6Strong Sell$4.00N/ADowngrades
a year ago
Vigil Neuroscience IncVIGL
1Strong Sell$4.00N/ADowngrades
a year ago
Invivyd IncIVVD
1Hold$4.00N/AUpgrades
a year ago
Bluebird Bio IncBLUE
1Hold$140.00N/AUpgrades
a year ago
Ultragenyx Pharmaceutical IncRARE
6Strong Buy$84.00N/AMaintains
a year ago
Bicycle Therapeutics PLCBCYC
4Hold$40.00N/AMaintains
a year ago
Immuneering CorpIMRX
3Hold$14.00N/AMaintains
2 years ago
Esperion Therapeutics IncESPR
7Hold$3.00N/AMaintains
2 years ago
Repare Therapeutics IncRPTX
5Hold$14.00N/AMaintains
2 years ago
Lenz Therapeutics IncLENZ
4Hold$3.00N/AMaintains
2 years ago
Cyteir Therapeutics IncCYTT
3Strong Sell$2.00N/ADowngrades
2 years ago
Celularity IncCELU
3Strong Sell$10.00N/ADowngrades
2 years ago
Cincor Pharma IncCINC
6Hold$30.00N/AMaintains
2 years ago
Exelixis IncEXEL
2Hold$22.00N/AMaintains
2 years ago
Rubius Therapeutics IncRUBY
3Hold$1.50N/AMaintains
3 years ago
Evofem Biosciences IncEVFM
6Strong Sell$0.75N/AMaintains
3 years ago
Biohaven Pharmaceutical Holding Co LtdBHVN1
1Hold$146.00N/AMaintains
3 years ago
Acceleron Pharma IncXLRN
3Hold$180.00N/ADowngrades
4 years ago
Aprea Therapeutics IncAPRE
5Strong Sell$60.00N/ADowngrades
4 years ago
Voyager Therapeutics IncVYGR
2Hold$7.00N/AMaintains
4 years ago
Myokardia IncMYOK
2Hold$225.00N/ADowngrades
5 years ago
Nextcure IncNXTC
1Strong Buy$58.00N/AMaintains
5 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.